KUCHYNKA, Michaela, Tereza PADRTOVÁ, Peter SCHEER, Jana HLOŽKOVÁ, Radka OPATŘILOVÁ, Marcela VLČNOVSKÁ, Markéta VACULOVIČOVÁ, Jan BISKUPIČ, Viktor KANICKÝ, Hossein MOHAMMADPOUR, Tomáš ZIKMUND, Jozef KAISER and Tomáš VACULOVIČ. NANO-SAVERS, POTENTIAL THERANOSTICS FOR STROKE DETECTION AND TREATMENT: INVESTIGATION OF THEIR PHARMACOKINETICS. In European Winter Conference on Plasma Spectrochemistry. 2023. ISBN 978-961-6104-85-2.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name NANO-SAVERS, POTENTIAL THERANOSTICS FOR STROKE DETECTION AND TREATMENT: INVESTIGATION OF THEIR PHARMACOKINETICS
Authors KUCHYNKA, Michaela (203 Czech Republic, guarantor, belonging to the institution), Tereza PADRTOVÁ (203 Czech Republic, belonging to the institution), Peter SCHEER (203 Czech Republic, belonging to the institution), Jana HLOŽKOVÁ (203 Czech Republic, belonging to the institution), Radka OPATŘILOVÁ (203 Czech Republic, belonging to the institution), Marcela VLČNOVSKÁ (203 Czech Republic, belonging to the institution), Markéta VACULOVIČOVÁ (203 Czech Republic), Jan BISKUPIČ (203 Czech Republic, belonging to the institution), Viktor KANICKÝ (203 Czech Republic, belonging to the institution), Hossein MOHAMMADPOUR (826 United Kingdom of Great Britain and Northern Ireland), Tomáš ZIKMUND (203 Czech Republic), Jozef KAISER (203 Czech Republic) and Tomáš VACULOVIČ (203 Czech Republic, belonging to the institution).
Edition European Winter Conference on Plasma Spectrochemistry, 2023.
Other information
Original language English
Type of outcome Presentations at conferences
Field of Study 10406 Analytical chemistry
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW European Winter Conference on Plasma Spectrochemistry
RIV identification code RIV/00216224:14160/23:00134714
Organization unit Faculty of Pharmacy
ISBN 978-961-6104-85-2
Keywords (in Czech) biologické zobrazování; laserová ablace; detekce proteinu; prvková distribuce
Keywords in English Bioimaging; laser ablation; protein detection; element distribution
Tags PATFYZ, ÚCh, ÚChL, ÚFTo
Tags International impact, Reviewed
Changed by Changed by: Mgr. Michaela Kuchynka, Ph.D., učo 358018. Changed: 6/6/2024 15:54.
Abstract
In the last decades, increased interest in imaging of elements/metals/proteins distribution, mainly in pharmaceutical, biomedicine research, or life science with direct application of research to specific problem/disease [1-3]. As WHO data indicates, cerebrovascular events are one of the main causes of mortality in developed nations. The key to success is time (as short as possible). Biodegradable iodinated nanoparticles (IoNPs) could be an invaluable addition to the existing contrast agents used in medicine. A complete investigation into the pharmacokinetics and dynamics of Ion-based Nanoparticles (IoNPs) is essential to address this issue. With the combination of CT and LA-ICP-MS imaging, this comprehensive evaluation verifies the treatment strategy's overall success, positioning LA-ICP-MS as a potential "gold standard" imaging method for researching and applying IoNPs in theranostics. Nowadays, LA-ICP-MS is also starting to be used as a technique for the simultaneous specific determination of the protein of interest, which opens up the possibility of achieving the so-called multiplex analysis. Protein determination, protein imaging and finally their distribution in clinical samples are presented. Proteins are imaged using an immunohistochemical method (binding nanoparticle-labeled antibodies to a specific protein) and LA-ICP-MS. The main advantages of utilizing LA-ICP-MS are the acquisition of comprehensive (Metallo)proteomic information about the tissue of a given disease (in this case, cancer or stroke) or low detection limits compared to other conventionally employed protein imaging techniques in combination with multiplex analysis of one sample.
Links
MUNI/R/1568/2020, interní kód MUName: Study the effectiveness of anticancer drugs (Acronym: STEAD)
Investor: Masaryk University, CAREER RESTART
NU21-08-00510, research and development projectName: Biokompatibilní nanočástice jako cílené systémy pro dodávání léčiv a teranostik pro léčbu cévní mozkové příhody
Investor: Ministry of Health of the CR
PrintDisplayed: 29/7/2024 15:22